Clinical Trial Update: Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator

View source ↗

Summary

A Cleveland Clinic-sponsored trial investigating whether vasopressin hemodynamic response can identify septic shock subphenotypes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Shock, Septic | Status: TERMINATED